AI startup coverage leans heavily on growth metrics - users added, revenue growth, time to a funding milestone - because they're easy to report and make for a clean headline. A quieter metric predicts long-term survival more reliably: what happens to usage once a free trial, pilot, or promotional pricing period ends and a customer has to decide, with their own money, whether to keep using the product.
Why growth alone is a weak signal in AI specifically
Generative AI's novelty has driven a wave of trial usage that doesn't necessarily reflect durable value - curiosity, one-off experimentation, and free-tier usage all show up as growth without indicating whether a product has found a real, ongoing use case for its users. A startup can show impressive growth curves built almost entirely on this kind of low-commitment usage.
What retention after the honeymoon period reveals
The customers who convert to paid, ongoing usage after a trial ends are the ones who've found a genuine, repeatable use for the product, and the size of that group relative to total trial users is a much cleaner signal of product-market fit than raw growth. A startup with modest overall growth but strong post-trial retention is often in a healthier position than one with explosive growth and a steep drop-off once free access ends.
Why this metric is harder to find publicly
Growth numbers make for a good press release; post-trial retention rates generally don't get disclosed voluntarily, because they're less flattering and more revealing of a company's actual health. Investors doing real diligence ask for this number directly rather than relying on public reporting, which mostly doesn't have it.
What this means for reading startup coverage
A reported growth figure for an AI startup is a real but incomplete data point. The more informative, harder-to-get number is what fraction of that growth survives contact with an actual purchasing decision.